Feb 27, 2020 - Health

First supervised drug injection site in U.S. to open in Philadelphia

Advocates for safe injection sites rally in front of the James A Byrne Federal Courthouse in Center City, Philadelphia, on Sept. 5, 2019. Photo: Cory Clark/NurPhoto via Getty Images

The nation's first supervised drug-use site is set to open in Philadelphia next week, after a federal judge ruled Tuesday in favor of the nonprofit that plans to open it, the Wall Street Journal reports.

The big picture: Advocates of such sites say that they help prevent deadly overdoses while potentially helping connect users with treatment, but federal law enforcement officials have said that they think such sites are illegal. The Justice Department — which brought the lawsuit against the nonprofit — said it's appealing the decision.

Go deeper: Opioid death rate in the U.S. decreased in 2018

Editor's note: The image has been changed to reflect a rally the supervised drug-use site in Philadelphia.

Go deeper

Drugmakers warn of medication shortages from coronavirus

Tourists with face masks walk through Union Square in New York City on Feb. 28. Photo: Timothy A. Clary/AFP via Getty Images

Some of the largest drugmakers — including AstraZeneca, Merck and Pfizer — have said that the coronavirus outbreak could affect their supplies or sales, the Wall Street Journal reports.

Between the lines: Drug shortages can end up being incredibly serious for patients, but they're not good for business either.

Go deeperArrowMar 2, 2020 - Health

Possible coronavirus drug causes poisonings in Nigeria

Photo: Alex Wong/Getty Images

Nigeria is reporting two poisonings from the drug chloroquine, a drug that's been touted as a potential but as-yet unproven treatment for coronavirus, Bloomberg reports.

Reality check: Health officials are warning against self-medicating with the drug, whose safety and effectiveness for coronavirus patients has not been proven.

Go deeperArrowMar 21, 2020 - Health

Chloroquine, an old anti-malarial drug, takes the coronavirus spotlight

A worker checks the production of chloroquine in China. Photo: Feature China/Barcroft Media via Getty Images

The Trump administration is taking a very public interest in chloroquine, an old, cheap anti-malarial drug, as a potential coronavirus treatment, although it's way too soon to put much stock in its effectiveness.

What they're saying: The Food and Drug Administration is investigating whether the drug can reduce the duration of patients' symptoms in mild to moderate cases, or to reduce "viral shedding," which helps prevent disease spread.

Go deeperArrowMar 20, 2020 - Health